Author： Curtis Kathryn
Publisher： Springer Publishing Company
ISSN： 1389-9155
Source： Reviews in Endocrine and Metabolic Disorders, Vol.12, Iss.2, 2011-06, pp. : 119-125
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Medical eligibility criteria for contraceptive use
Human Fertility, Vol. 14, Iss. 3, 2011-09 ,pp. :
Access to resources
Recommend
Third generation oral contraceptive use and cardiovascular risk factors
By Doring A. Frohlich M. Lowel H. Koenig W.
Atherosclerosis, Vol. 172, Iss. 2, 2004-02 ,pp. :
Prothrombin 20210A and Oral Contraceptive Use as Risk Factors for Cerebral Venous Thrombosis
Cerebrovascular Diseases, Vol. 19, Iss. 1, 2005-01 ,pp. :
By Takamura M. Koga K. Osuga Y. Takemura Y. Hamasaki K. Hirota Y. Yoshino O. Taketani Y.
Human Reproduction, Vol. 24, Iss. 12, 2009-12 ,pp. :